Skin Cancer

When tissue conservation is critical, Mohs surgery remains the standard of care in skin cancer removal, allowing clinicians greater margin control than some treatment alternatives.

Because the impact of elevated vitamin D levels in areas other than bone health has yet to be established, an expert recommends oral supplementation and maximum sun protection for patients with melanoma.

A newly formed group of indoor tanning retailers is working to correct what it calls “misinformation” about tanning beds and boost public awareness of the potential benefits of UV exposure.

The Skin Cancer Foundation has filed a complaint with the Federal Trade Commission regarding what it calls the “dangerous” promotion of indoor tanning on the MTV show “Jersey Shore.”

A fractional resurfacing technique that uses a 1927 nm nonablative thulium laser reduces the number of facial actinic keratosis and provides noticeable clearance of photodamage, results of a recent study indicate.

Consumers who use smartphone applications to analyze suspicious lesions or moles are at risk of having inaccurate diagnoses and delayed treatments, results of a new study indicate.

Intermittent dosing of vemurafenib extended the lives of lab mice with drug-resistant melanoma tumors, according to results of an international study.

Exposure to ultraviolet nail lamps does not increase the risk of developing skin cancer, a recent study indicates.

Imiquimod shows promise for treating cases of melanoma in situ that aren’t amenable to surgery, and for other off-label indications such as metastatic melanoma, says M. Shane Chapman, M.D.

The decision to perform a sentinel lymph node biopsy (SLNB) in patients with melanoma requires considering many factors, including the patient’s input, says Clara Curiel-Lewandrowski, M.D.

High-tech imaging modalities are helpful in detecting metastatic neural spread of tumors, a process known as perineural spread (PNS), and thus can be instrumental in better managing the patient, says Barton Lane, M.D.

Despite the number of currently available options for the treatment of actinic keratoses (AKs), dermatologists are still challenged by the occasional patient with widespread lesions refractory to multiple modalities.